US Stock MarketDetailed Quotes

ORKA Oruka Therapeutics

Watchlist
  • 24.890
  • -1.110-4.27%
Close Sep 13 16:00 ET
  • 24.890
  • 0.0000.00%
Post 20:01 ET
731.73MMarket Cap-65500P/E (TTM)

About Oruka Therapeutics Company

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Westminster, CO.

Company Profile

SymbolORKA
Company NameOruka Therapeutics
Listing DateAug 8, 1997
CEODr. Lawrence Otto Klein, PhD
MarketNASDAQ
Address10170 Church Ranch Way,Suite 100
CityWestminster
ProvinceColorado
CountryUnited States of America
Zip Code80021
Phone1-720-940-2100
Websitehttp://www.orukatx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lawrence Otto Klein, PhD
  • Director, President and Chief Executive Officer
  • --
  • Dr. Joana Goncalves, M.D.
  • Chief Medical Officer
  • --
  • Arjun Agarwal
  • Senior Vice President, Finance and Treasurer
  • --
  • Dr. Samarth Kulkarni, PhD
  • Chairman of the Board
  • --
  • Dr. Carl Dambkowski, M.D.
  • Independent Director
  • --
  • Peter Harwin
  • Independent Director
  • --
  • Dr. Cameron Turtle, D.Phil.
  • Independent Director
  • --
  • Kristine M. Ball
  • Independent Director
  • --
  • Paul T. Quinlan PhD
  • General Counsel and Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data